AGENDA

Friday, September 255:15 - 6:00 Reception6:00 - 6:05 Opening Remarks - Jim Slater, CEO Diagnostic Services Manitoba6:05 - 6:10 Greetings from The Honourable Sharon Blady, Minister of Health6:10 - 6:40 Diagnostic Services Manitoba Annual General Meeting

- Greetings from Board Chair, Marie Perchotte (5 minutes) - Overview of Annual Achievements, Jim Slater (10 minutes) - Open Discussion / Q&A (15 minutes)

6:40 - 7:40 Dr. Patrick Croskerry: Clinical Cognition and Diagnostic Error: Applications of a Dual Process Model of Decision Making

8:00 - 8:30 Registration & Breakfast8:30 - 9:30 Dr. Emina Torlakovic: Standardization of Controls for Diagnostic

Immunohistochemistry; Introducing Immunohistochemistry Critical IHC Assay Performance Controls (iCAPCs)

9:30 - 10:30 Dr. Richard Zarbo: Transforming to a Lean Culture of Continuous Improvement10:30 - 10:45 Refreshment Break10:45 - 11:45 Dr. Manon Auger: Quality Assurance in Cytopathology: Key Issues and New

Strategies11:45 - 12:30 Lunch12:30 - 1:30 Dr. Kathryn Reducka: Communication & Documentation Pitfalls in Pathology1:30 - 2:30 Panel Discussion2:30 - 2:45 Wrap-up, Closing Remarks & Evaluation

Saturday, September 26

September 25-26, 2015 • RBC Convention Centre • Winnipeg, ManitobaSeptember 25-26, 2015 • RBC Convention Centre • Winnipeg, Manitoba

SHAPING THE FUTURE OF QUALITY IMPROVEMENTS IN PATHOLOGY III

DSM Conference 2015

DIAGNOSTIC SERVICES MANITOBA

Endorsed by:

September 25-26, 2015 • RBC Convention Centre • Winnipeg, ManitobaSeptember 25-26, 2015 • RBC Convention Centre • Winnipeg, Manitoba

SHAPING THE FUTURE OF QUALITY IMPROVEMENTS IN PATHOLOGY III

DSM Conference 2015

Dr. Emina TorlakovicDr. Emina Emilia Torlakovic obtained her M.D. at the University of Zagreb Medical School and her Ph.D. at the University of Oslo Medical School. She is board certified by The American Board of Pathology in Anatomic and Clinical Pathology with subspecialty boards in Hematopathology. She is an associate professor at the Department of Laboratory Medicine and Pathobiology,

Faculty of Medicine, University of Toronto. She was one of the co-founders of the NordiQC and CIQC. Dr. Torlakovic is the Chair of the National Standards Committee for High Complexity Testing of the CAP-ACP. This committee prepared and published several Canadian guidelines for standardization of IHC testing. Dr. Torlakovic chairs the International Council for Standardization in Hematology Working Party for Standardization of Bone Marrow Immunohistochemistry, which is developing international guidelines for bone marrow IHC. She was also a member of the ASCO/CAP expert panel that published guidelines for hormone receptor testing in breast cancer. She is also currently leading projects related to global standardization of controls in diagnostic IHC.

Dr. Torlakovic is also known for a discovery of a sessile serrated adenoma and her classification of serrated polyps of the colon is recently adopted for WHO classification.

Dr. Torlakovic has published over 80 peer reviewed manuscripts, authored a book on Bone Marrow Immunohistochemistry, and has lectured widely nationally and internationally on immunohistochemistry, quality assurance, and hematopathology.

ABOUT OUR SPEAKERS Dr. Patrick CroskerryPat Croskerry is a Professor in Emergency Medicine and in the Division of Medical Education at Dalhousie University, Halifax, Nova Scotia. In addition to his medical training, he holds a doctorate in Experimental Psychology and Fellowship in Clinical Psychology. He has worked in the area of Patient Safety for the last 15 years and has given over 500 talks on the topic at local, national

and international levels, including the Great Ormond Street Hospital for Children, the Mayo Clinic, Case Western Reserve, and Harvard Medical School. He established the first Canadian Symposium on Patient Safety in 2001 in Halifax, which continued annually until 2010. In 2006 he received the Ruedy award from the Association of Faculties of Medicine of Canada for innovation in medical education, and in the same year was appointed to the Board of the Canadian Patient Safety Institute.

His research is principally concerned with clinical decision-making, especially the processes that lead to diagnostic failure. He was a member of the organizing committee of the first conference on Diagnostic Error in Phoenix, Arizona in 2008 and on the Los Angeles conference in 2009. He has contributed at each national conference since. He has published over 80 journal articles and 30 book chapters in the area of patient safety, clinical decision making, and medical education reform. He is senior editor on a major text Patient Safety in Emergency Medicine published in 2009, and senior author of Diagnosis due out in 2015. He was appointed Director of the new Critical Thinking Program at Dalhousie Medical School, and a Fellow of the Royal College of Physicians of Edinburgh in 2012. In 2014, he was appointed to the US Institute of Medicine Committee on Diagnostic Error in Medicine.

DIAGNOSTIC SERVICES MANITOBA

Endorsed by:

September 25-26, 2015 • RBC Convention Centre • Winnipeg, ManitobaSeptember 25-26, 2015 • RBC Convention Centre • Winnipeg, Manitoba

SHAPING THE FUTURE OF QUALITY IMPROVEMENTS IN PATHOLOGY III

DSM Conference 2015

DIAGNOSTIC SERVICES MANITOBA

Dr. Richard ZarboRichard Zarbo, MD, DMD is the senior vice-president and KD Ward Chair of Pathology and Laboratory Medicine in the Henry Ford Health System and past-president of the United States and Canadian Academy of Pathology. He is a board certified anatomic and clinical pathologist and an expert in head and neck pathology, laboratory quality

and continuous process improvement. Dr. Zarbo was initially instrumental in defining national benchmarks of laboratory quality since 1990 through the CAP Q-Probes and Q-Tracks programs. These collaborative studies of laboratory quality produced more than a hundred peer reviewed publications and - in the successful Q-Tracks - the only national set of pathology and laboratory quality measures that have been validated to show quality improvement, over time, in real practice settings.

Dr. Zarbo is a transformative leader who has integrated the laboratories of the Ford System into a product-line and has been one of the pathology profession’s early pioneers in applying quality techniques and principles of Lean manufacturing to pathology and laboratory medicine for the past 9 years. The Henry Ford continuous improvement culture is based on quality manufacturing principles developed by Henry Ford and the management approach of W. Edwards Deming that later inspired the innovations of the Toyota Production System. This successful Lean culture of the Henry Ford laboratories that produced thousands of process improvements is featured in Dr. Jeffrey Liker’s book - The Toyota Way to Continuous Improvement: Linking Strategy and Operational Excellence to Achieve Superior Performance. The Henry Ford Laboratories obtained ISO 15189 accreditation in 2013 as the largest ISO 15189 accredited integrated, multi-setting medical laboratory system in the US. Dr. Zarbo’s curriculum vitae includes over 200 peer reviewed publications, with over 50 directly related to laboratory quality. He is clinical professor of Pathology at Wayne State University School of Medicine.

Dr. Manon AugerAfter obtaining her MD degree at McGill University, Dr. Auger completed her residency training in Anatomical Pathology at the University of Toronto, followed by a Cytopathology Fellowship at the University of Texas M.D. Anderson Cancer Center in Houston. She is Director of the Cytopathology Laboratory at the McGill University Health Center and

is Professor in the Department of Pathology at McGill University. Her interests relate to all aspects of cytopathology, including quality assurance and, in particular, rapid prescreening.

Dr. Kathryn ReduckaDr. Kathryn Reducka graduated from the University of Alberta in 1983. From 1987 to 2006, she maintained a general practice in Pembroke, Ontario which included obstetrics at the Pembroke Regional Hospital. Dr. Reducka was president of the medical staff at the Pembroke Regional Hospital for many years and sat on numerous hospital

committees, including Credentials and Maternal Child Care. She also served the medical community through committees of the Ontario Medical Association, chairing the Women’s Issues Committee. In addition, she was president of Renfrew County Medical Society. Dr. Reducka joined the Canadian Medical Protective Association as a physician risk manager in 2006.

Endorsed by: